Cover Image
市場調查報告書

老年癡呆症治療藥的全球市場趨勢、機會、預測 2015-2020年:影像、治療方法、診斷、生物標記

Global Alzheimer's Drug Market: Trends, Opportunities and Forecasts 2015-2020

出版商 Azoth Analytics 商品編碼 346774
出版日期 內容資訊 英文 106 Pages
訂單完成後即時交付
價格
Back to Top
老年癡呆症治療藥的全球市場趨勢、機會、預測 2015-2020年:影像、治療方法、診斷、生物標記 Global Alzheimer's Drug Market: Trends, Opportunities and Forecasts 2015-2020
出版日期: 2015年12月08日 內容資訊: 英文 106 Pages
簡介

全球老年癡呆症市場,預計從2015年到2020年顯示8.54%的年複合成長率。各地區中,亞太地區2014年構成的收益佔有率的大部分,預計這個趨勢繼續到2020年。

本報告提供全球老年癡呆症市場相關調查、各市場規模/佔有率/預測、市場區隔分析 (治療方法、診斷&生物標記、影像部門、患者、治療藥) 、政策與法規環境,與市場趨勢的變化與新的機會、競爭情形策略性建議,及主要企業的簡介等彙整。

第1章 調查手法

第2章 老年癡呆症市場概要

第3章 全球老年癡呆症市場展望

第4章 全球老年癡呆症市場

  • 各治療法
  • 各診斷法、生物標記
  • 各影像部門
  • 各病理修飾療法 (DMT)

第5章 全球老年癡呆症市場展望:各人口動態 (年齡族群)

第6章 全球老年癡呆症市場展望:各治療藥物

第7章 全球老年癡呆症市場展望:各地區

第8章 美國的老年癡呆症市場展望

  • 美國的癡呆症市場展望

第9章 全球癡呆症市場展望

第10章 全球癡呆症市場展望

  • 各地區的分析
    • 亞太地區的癡呆症市場展望
  • 各國
    • 各低所得國分析
    • 前10大國家分析

第11章 市場動態

  • 促進要素
  • 課題

第12章 市場趨勢、發展

第13章 競爭情形

  • 銷售額比較:前五名公司
  • EBITDA比較:前五名公司
  • EBIT比較:前五名公司
  • PBT比較:前五名公司
  • PAT比較:前五名公司
  • 流動比率比較:前五名公司

第14章 企業簡介

  • Pfizer Inc.
  • Novartis International AG
  • Axovant Sciences Ltd.
  • Acadia Pharmaceuticals
  • Biotie Therapies

圖表清單

目錄

Executive Summary

Progressive numbers of neurological disorders along with escalating demand for drugs to control of Alzheimer Disease.

The Global Alzheimer's Market is growing at a moderate rate over last five years on account of rising expenditure on health care especially neurological disorders among ageing population and escalating role of private and government bodies in empowering R&D measures to avoid degenerative disorders. During 2015-20, Global Alzheimer Disease Market is anticipated to grow at an increased rate on account of robust expansion plans of the increase in medical facilities. Moreover, increase in number of patients suffering from degenerative disorder is further anticipated to boost the Global Alzheimer's market in the coming years.

According to Azoth Analytics research report, “Global Alzheimer's Drug Market: Trends, Opportunities and Forecasts (2015-2020) - (By Type - Imaging, Therapeutics, Diagnostics, Biomarkers; By Age: <65 years, >65 years; By Region; Global Dementia Market)”, global Alzheimer's market is projected to exhibit a CAGR of over 8.54% during 2015-2020. On the basis of Reisberg Scale, market is categorized by seven stages of Alzheimer. Alzheimer is expected to be cured by Drugs; Exercise and Nutrition. Growth in Alzheimer's Drug market is anticipated to grow in the next five years. Asia Pacific region dominated the revenue contribution share in 2014 and the region is forecast to continue its domination through 2020. Few of the leading companies operating in Global Alzheimer's Disease Market include Axovant Sciences Ltd., Biotie Therapies, Acadia Pharmaceuticals, Novartis International AG and many more.

Scope of the Report

The report “Global Alzheimer's Drug Market: Trends, Opportunities and Forecasts (2015-2020) - (By Type - Imaging, Therapeutics, Diagnostics, Biomarkers; By Age: >65 years, <65 years; By Region; Global Dementia Market)” analyzes the following aspects of global Alzheimer's market:

  • Global Alzheimer's Market Size, Share & Forecast
  • Segmental Analysis - By Therapeutics, By Diagnostics and Biomarkers, By Imaging Sector, By Patient and By Drugs
  • Policy & Regulatory Landscape
  • Market Entry Strategies for Domestic/Foreign Players
  • Changing Market Trends & Emerging Opportunities
  • Competitive Landscape & Strategic Recommendations

Why You Should Buy This Report?

  • 1. To gain an in-depth understanding of Alzheimer disease and dementia market propelling globally.
  • 2. To identify the on-going trends and anticipated growth in the next five years
  • 3. To help industry consultants, drug and diagnostics manufacturers, vendors and dealers align their market-centric strategies
  • 4. To obtain research based business decision and add weight to presentations and marketing material
  • 5. To gain competitive knowledge of leading players
  • 6. To avail limited customization in the report without any extra charges and get research data or trends added in the report as per the buyer's specific needs

Table of Contents

1. Research Methodology

2. Alzheimer's Disease Market Overview

3. Global Alzheimer's Disease Market Outlook

4. Global Alzheimer's Disease Market

  • 4.1. By Therapeutics
  • 4.2. By Diagnostics and Biomarkers
  • 4.3. By Imaging Sector
  • 4.4. By Disease Modifying Therapeutics

5. Global Alzheimer's Disease Market Outlook-By Demographic (Age-Group)

6. Global Alzheimer's Disease Market Outlook-By Drug

7. Global Alzheimer's Disease Market Outlook-By Region

8. United States Alzheimer's Disease Market Outlook

  • 8.1. United States Dementia Market Outlook

9. Global Dementia Disease Market Outlook

10. Global Dementia Disease Market Outlook

  • 10.1. By Regional Break-Up
    • 10.1.1. Asia-Pacific Dementia Market Outlook
  • 10.2. By Countries
    • 10.2.1. Low Income Country -wise Break up
    • 10.2.2. Top Ten Country-wise Break-Up
      • Australia Dementia Market Outlook
      • UK Dementia Market Outlook

11. Market Dynamics

  • 11.1. Drivers
  • 11.2. Challenges

12. Market Trends & Developments

13. Competitive Landscape

  • 13.1. Sales Comparatives, Top 5 Companies
  • 13.2. EBITDA Comparatives, Top 5 Companies
  • 13.3. EBIT Comparatives, Top 5 Companies
  • 13.4. PBT Comparatives, Top 5 Companies
  • 13.5. PAT Comparatives, Top 5 Companies
  • 13.6. Current Ratio Comparatives, Top 5 Companies

14. Company Profiling

  • 14.1. Pfizer Inc.
  • 14.2. Novartis International AG
  • 14.3. Axovant Sciences Ltd.
  • 14.4. Acadia Pharmaceuticals
  • 14.5. Biotie Therapies
  • 1. Global Alzheimer's Disease Market Size ,By Value (USD Billion) and Volume (Number of Patients in Million) 2010-2020F
  • 2. Global Alzheimer's Disease Market by Therapeutics ,By Value (USD Million) 2010-2020F
  • 3. Global Alzheimer's Market share, By Therapeutics
  • 4. Global Alzheimer's Disease Market , By Diagnostics and Biomarkers ,By Value (USD Billion)
  • 5. Global Alzheimer's Disease Market, By Imaging Sector, By Value (USD Million)
  • 6. Global Alzheimer's Disease Market by Disease Modifying Therapeutics Market Size ,By Value (USD Million)
  • 7. Global Alzheimer's Disease Market, By Demographics, By Age < 65, By Volume (Number of patients in million),2010-2020F
  • 8. Global Alzheimer's Disease Market, By Demographics, By Age > 65, By Volume (Number of patients in million),2010-2020F
  • 9. Global Memantine (Nameda) Drug Market Size ,By Value (USD Billion) and Volume (Number of Patients in Million) 2010-2020F
  • 10. United States Dementia Disease Market Size ,By Value (USD Million) and Volume (Number of Patients In Million) 2010-2020F
  • 11. Cost of Alzheimer Disease in United States, By Payer, By percentage, 2010-14
  • 12. U.S. Alzheimer's Drug RTV-101 Market , By Value & Penetration Rate; 2019-2027 (USD Million)
  • 13. U.S. Alzheimer's Drug Azeliragon Market, By Value & Penetration Rate, 2019-2027 (USD Million)
  • 14. U.S. Annual Alzheimer's Death Rates ,By Age; 2006-2013
  • 15. U.S. Annual Alzheimer's Death Rates ,By Age; 2006-2013
  • 16. Global Dementia Disease Market Size ,By Value (USD Million) and Volume (Number of Patients In Million) 2010-2020F
  • 17. Global Dementia Disease Market Size , By Volume (Number of Patients In Million), By Region 2014
  • 18. Global Dementia Disease Market Size , By Number of new cases, By Volume (Number of Patients In Million), By Region 2014
  • 19. Asia-Pacific Dementia Disease Market Size , By Volume (Number of Patients In Million), By country 2015E,2030F,2050F
  • 20. Global Dementia Disease Market Size , By Volume (Number of Patients In Million), By Region 2014
  • 21. Global Dementia Disease Market Size Low Income Countries ,Volume (Number of Patients In Million) 2010-2020F
  • 22. Global Dementia Disease Market Size Low Income Countries ,Volume (Number of Patients In Million) 2010-2020F
  • 23. Global Dementia Disease Market Size in Top Ten Countries ,Volume (Number of Patients In Million) 2010-2020F
  • 24. Australia Dementia Disease Market Size , By Volume (Number of Patients In Million) 2010-2020F
  • 25. Australia Dementia Disease Market Size , By Volume (Number of Patients In Million) 2010-2020F
  • 26. UK Dementia Market, By Type, 2014 (%)
  • 27. UK Dementia Cost, By Type of Service, 2014 (%)
  • 28. Number of Unpaid Caregivers (In Million)
  • 29. Pfizer Revenue (USD Million) AY 2011-2014
  • 30. Axovant Services Ltd. Revenue (USD Million) FY 2011-2015
  • 31. Pfizer Percentage Revenue, By Business Segment (2014)
  • 32. Pfizer Percentage Revenue, By Geography (2014)
  • 33. Novartis International AG Revenue (USD Million) AY 2011-2014
  • 34. Novartis International AG Percentage Revenue, By Business Segment (2014)
  • 35. Novartis International AG Percentage Revenue, By Geography (2014)
  • 36. Axovant Services Ltd. Revenue (USD Million) FY 2011-2015
  • 37. Axovant Services Ltd. Percentage Revenue, By Business Segment (2014)
  • 38. Axovant Services Ltd. Percentage Revenue, By Geography (2014)
  • 39. Acadia Pharmaceuticals Revenue (USD Million) AY 2011-2014
  • 40. Acadia Pharmaceuticals Percentage Revenue, By Business Segment (2014)
  • 41. Acadia Pharmaceuticals Percentage Revenue, By Geography (2014)
  • 42. Biotie Therapies Revenue (USD Million) AY 2011-2014
  • 43. Biotie Therapies Percentage Revenue, By Business Segment (2014)
  • 44. Sales Comparatives, Top 5 Companies, 2011-2014
  • 45. EBITDA Comparatives, Top 5 Companies, 2011-2015
  • 46. EBIT Comparatives, Top 5 Companies, 2011-2015
  • 47. PBT Comparatives, Top 5 Companies, 2011-2015
  • 48. PAT Comparatives, Top 5 Companies, 2011-2015
  • 49. Current Ratio Comparatives, Top 5 Companies, 2011-2015
  • 50. Profit Margin Ratio Comparatives, Top 5 Companies, 2011-2015
  • 51. Debt Equity Ratio Comparatives, Top 5 Companies, 2011-2015
Back to Top